ABREA

Active ingredients

The drug ABREA contains one active pharmaceutical ingredient (API):

UNII R16CO5Y76E - ASPIRIN

Acetylsalicylic acid combines significant advantages such as strong anti-pyretic, analgesic and anti-inflammatory action, that is the measure of comparison with all the newer NSAIDs.

Read about Acetylsalicylic acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
B01AC06
Acetylsalicylic acid
B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC06

Authorization and marketing

This brand name is authorized in the following countries: Lithuania Poland

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s): 1079508, 1079509, 1079510, 1082012, 1082013, 1082014, 1082015, 1082016, 1082017, 1082018, 1082019, 1082020, 1082021, 1082022, 1082023, 1082024, 1082025, 1082026, 1082027, 1082028, 1082029, 1082030, 1082031, 1082032, 1082033
PL
Rejestru Produktów Leczniczych
Identifier(s): 100364986, 100364992, 100365000